tiprankstipranks
Spero Therapeutics (SPRO)
NASDAQ:SPRO
SPRO
Spero Therapeutics
RESEARCH TOOLSreports

Spero Therapeutics (SPRO) Revenue

585 Followers
StatisticsMarket CapRevenue

Spero Therapeutics Revenue

Spero Therapeutics had a revenue of 38.90M in the quarter ending Dec 31, 2025, with 1176.08%. This bring the company's revenue in the last twelve months to 59.62M, Decreased 66.68%. In the fiscal year ending Dec 31, 2025, Spero Therapeutics had annual revenue of 59.62M with 24.27% growth.
Revenue (ttm)
59.62M
Revenue Growth
-67.38%
P/S Ratio
2.36
Revenue/Employee
$1,863,094
Employees
32
Market Cap
$140.68M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
59.62M11.64M+24.27%
Dec 31, 2024
47.98M-55.80M-53.77%
Dec 31, 2023
103.78M55.20M+113.63%
Dec 31, 2022
48.58M45.51M+1,482.38%
Mar 31, 2022
3.07M-6.26M-67.10%
Dec 31, 2020
9.33M-8.82M-48.59%
Dec 31, 2019
18.15M14.18M+357.56%
Dec 31, 2018
3.97M1.99M+100.40%
Dec 31, 2017
1.98M――